About this trial
The purpose of this study was to explore the accuracy of sentinel skin grafts from the same donor source in diagnosing renal allograft rejection, and to provide new ideas and options for the later clinical diagnosis of renal allograft rejection. Further, try to provide timing guidance for early immunization intervention.
Eligibility criteria
Qualifiers
Patients with end-stage renal disease undergoing renal transplantation;
18-60 years old;
Postoperative follow-up points are complete (visit the hospital every week in the first month after surgery, every two weeks in 2-3 months, every four to six months, and every three months in 7-12 months. Follow up at any time when skin rejection is observed. The follow-up time may be adjusted when the condition changes);
The participants had good compliance, volunteered to participate in the test and signed the informed consent form.
Disqualifiers
Untreated or disseminated malignant tumor;
Active period of infectious diseases;
Serious cardiovascular disease occurred recently;
Combined with other important organ failure;
Trial design
Treatments tested in this trial
- Skin allotransplantation
Treatment groups
Sponsors and collaborators
Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead sponsor
Zhejiang University
Collaborator
Sir Run Run Shaw Hospital
Collaborator
The First Affiliated Hospital of Air Force Medicial University
Collaborator